Sentry LLC’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.17M Sell
37,523
-1,261
-3% -$294K 2.92% 6
2025
Q4
$8.03M Sell
38,784
-100
-0.3% -$19.8K 2.2% 6
2025
Q3
$7.21M Sell
38,884
-800
-2% -$137K 1.79% 8
2025
Q2
$6.06M Hold
39,684
1.21% 9
2025
Q1
$6.58M Buy
39,684
+785
+2% +$123K 1.28% 7
2024
Q4
$5.63M Sell
38,899
-1,535
-4% -$238K 1.1% 10
2024
Q3
$6.55M Sell
40,434
-539
-1% -$85.9K 1.26% 9
2024
Q2
$5.99M Sell
40,973
-1
-0% -$149 1.1% 11
2024
Q1
$6.48M Sell
40,974
-250
-0.6% -$39.8K 1.22% 10
2023
Q4
$6.46M Sell
41,224
-56
-0.1% -$8.59K 1.37% 9
2023
Q3
$6.43M Buy
41,280
+300
+0.7% +$49.5K 1.36% 7
2023
Q2
$6.78M Hold
40,980
1.48% 7
2023
Q1
$6.35M Buy
+40,980
New +$6.62M 1.49% 6

Other funds holding JNJ

Sentry LLC's JNJ Position: Q1 2026 in Review

Sentry LLC reduced its Johnson & Johnson (JNJ) stake by 3.3% in Q1 2026, selling an estimated $294K and leaving 37,523 shares worth $9.17M. The position accounts for 2.92% of the portfolio, ranked #6.

Sentry LLC first reported a position in JNJ in Q1 2023 and has held it in 13 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Sentry LLC held 37,523 shares of Johnson & Johnson worth $9.17M as of Q1 2026.
  • Sentry LLC sold 1,261 Johnson & Johnson shares in Q1 2026, an estimated $294K.
  • Johnson & Johnson made up 2.92% of Sentry LLC's portfolio in Q1 2026, its #6 holding.
  • Sentry LLC first reported a position in Johnson & Johnson in Q1 2023 and has held it in 13 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Sentry LLC's 13F filing for Q1 2026, filed 23 Apr 2026.